RECURSION PHARMACEUTICALS, INC. Construction Payable, Current
RECURSION PHARMACEUTICALS, INC. (RXRX) had Construction Payable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:ConstructionPayableCurrent · last filed 2025-02-28
- 2024-12-31: Construction Payable, Current $0.00.
- 2024-09-30: Construction Payable, Current $0.00.
- 2024-06-30: Construction Payable, Current $0.00.
- 2024-03-31: Construction Payable, Current $0.00.
| Period end | Construction Payable, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.44M 10-K · filed 2025-02-28 |
| 2022-12-31 | $591.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.89M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.17M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.57M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $4.67M 10-K · filed 2023-02-27 |
| 2021-09-30 | $996.00K 10-Q · filed 2021-11-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |